Hemorrhoidalointment
NDC Package 69396-020-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Hemorrhoidalointment (mineral oil, petrolatum, phenylephrine hci) ointment is adults and children 12 years of age and older for topical use:Clean the affected area and pat or dab dry before applying ointmentApply to the affected area up to 4 times daily, especially after bowel movementAttach included applicator to tubeLubricate applicator tip and gently insert into rectumThoroughly clean applicator after each use and replace coverChildren under 12 years of age: ask a doctor before use. This formulation utilizes a ointment delivery system. Marketed by Trifecta Pharmaceuticals Usa Llc, this product is identified by NDC 69396-020 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
69396-020-33
Package Description
3 TUBE in 1 BOX / 56 g in 1 TUBE
Product Code
69396-020
11-Digit Billing Format
69396002033
RxNorm Crosswalk
  • RxCUI: 1372298 - mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Ointment
  • RxCUI: 1372298 - mineral oil 0.14 MG/MG / petrolatum 0.749 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment
  • RxCUI: 1372298 - mineral oil 14 % / petrolatum 74.9 % / phenylephrine hydrochloride 0.25 % Rectal Ointment

Clinical Specifications

Proprietary Name
Hemorrhoidalointment
Non-Proprietary Name
Mineral Oil, Petrolatum, Phenylephrine Hci
Substance Name
Mineral Oil; Petrolatum; Phenylephrine Hydrochloride
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 12 years of age and older for topical use:Clean the affected area and pat or dab dry before applying ointmentApply to the affected area up to 4 times daily, especially after bowel movementAttach included applicator to tubeLubricate applicator tip and gently insert into rectumThoroughly clean applicator after each use and replace coverChildren under 12 years of age: ask a doctor before use

Regulatory & Marketing

Labeler Name
Trifecta Pharmaceuticals Usa Llc
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-04-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69396-020). Click a package code to view its specific billing and regulatory data.

69396-020-01
1 TUBE in 1 BOX / 28.4 g in 1 TUBE
69396-020-02
1 TUBE in 1 BOX / 56 g in 1 TUBE
69396-020-05
1 TUBE in 1 BOX / 15 g in 1 TUBE
69396-020-44
4 TUBE in 1 BOX / 56 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69396-020-33 identifies a specific commercial package of 3 tube in 1 box / 56 g in 1 tube of Hemorrhoidalointment, a human over the counter drug labeled by Trifecta Pharmaceuticals Usa Llc. This ointment is formulated for topical use and contains mineral oil; petrolatum; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Trifecta Pharmaceuticals Usa Llc on May 04, 2017. The current certification is valid through December 31, 2026.

How is this Trifecta Pharmaceuticals Usa Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69396002033. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69396-020-33
11-Digit CMS (5-4-2)
69396-0020-33

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.